换一批
换一批Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: a randomized Phase II study.
第一作者：
Alfonso,Dueñas-González
第一单位：
Unidad de Investigación Biomédica en Cáncer, Instituto Nacional de Cancerología-Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, San Fernando no. 22, Tlalpan 14080, Mexico City, Mexico. aduenasg@incan.edu.mx
作者：
主题词
成年人(Adult);老年人(Aged);抗肿瘤药(Antineoplastic Agents);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌, 腺鳞状(Carcinoma, Adenosquamous);癌, 鳞状细胞(Carcinoma, Squamous Cell);顺铂(Cisplatin);综合疗法(Combined Modality Therapy);置信区间(Confidence Intervals);脱氧胞苷(Deoxycytidine);女(雌)性(Female);人类(Humans);中年人(Middle Aged);辐射增敏药(Radiation-Sensitizing Agents);放射治疗剂量(Radiotherapy Dosage);宫颈肿瘤(Uterine Cervical Neoplasms)
DOI
10.1016/j.ijrobp.2004.07.676
PMID
15708261
发布时间
2022-12-07
- 浏览36
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
